Jupiter Asset Management’s Prime Medicine PRME Stock Holding History

Jupiter Asset Management’s Portfolio PRME Stock Details PRME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$773K	Buy	+209,490	New	+$696K	﹤0.01%	456

Other funds holding PRME

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ACM

Alessandra Capital Management Torrance, California $141M AUM

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

KFGK

Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Jupiter Asset Management's PRME Position: Q2 2026 in Review

Jupiter Asset Management opened a new position in Prime Medicine (PRME) in Q2 2026: 209,490 shares worth $773K. The stake represents ﹤0.01% of the portfolio and ranks #456 among its holdings.

67 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

Jupiter Asset Management held 209,490 shares of Prime Medicine worth $773K as of Q2 2026.
Prime Medicine was a new Jupiter Asset Management position in Q2 2026.
Prime Medicine made up ﹤0.01% of Jupiter Asset Management's portfolio in Q2 2026, its #456 holding.
67 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.